Immunome Director Disposes $1.34M in Shares Across Two Trades
Immunome Inc. (NASDAQ:IMNM) director Philip Wagenheim sold 65,000 shares in two separate transactions disclosed on a Form 4, generating proceeds of $1,335,626. The trades occurred on March 20 and March 23, 2026, and followed a stock price that has risen 155% over the prior year to $20.76. Market commentary from InvestingPro flags potential overvalu…